Dizocilpine does not prevent the development of tolerance to the anxiolytic effects of diazepam in rats
- PMID: 9878864
- DOI: 10.1016/s0006-8993(98)01160-3
Dizocilpine does not prevent the development of tolerance to the anxiolytic effects of diazepam in rats
Abstract
The non-competitive NMDA receptor antagonist, dizocilpine (0.25 mg/kg), has previously been shown to block the development of tolerance to the sedative effects of diazepam (2 mg/kg). Since there is considerable evidence that different mechanisms underlie the development of tolerance to the sedative and anxiolytic effects of diazepam, the present experiment examined whether dizocilpine would block the development of tolerance to diazepam's anxiolytic effects. Rats tested after an acute dose of diazepam (2 mg/kg) showed an anxiolytic effect, measured by an increase in the time spent in social interaction, whereas those tested after 21 days of treatment had scores equal to the control group. This development of tolerance was not blocked by concomitant administration of dizocilpine (0.25 mg/kg). Thus, these results provide further evidence that the mechanism underlying tolerance to the anxiolytic effects of diazepam is different from that underlying tolerance to the sedative effects.
Copyright 1999 Published by Elsevier Science B.V.
Similar articles
-
The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam.Psychopharmacology (Berl). 1999 Aug;145(3):251-9. doi: 10.1007/s002130051056. Psychopharmacology (Berl). 1999. PMID: 10494573
-
Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats.Pharmacol Biochem Behav. 1994 Apr;47(4):823-6. doi: 10.1016/0091-3057(94)90282-8. Pharmacol Biochem Behav. 1994. PMID: 8029250
-
GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.PLoS One. 2012;7(8):e43054. doi: 10.1371/journal.pone.0043054. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912786 Free PMC article.
-
Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.Psychopharmacology (Berl). 1993;110(1-2):19-26. doi: 10.1007/BF02246946. Psychopharmacology (Berl). 1993. PMID: 7870883
-
Tolerance to the behavioral actions of benzodiazepines.Neurosci Biobehav Rev. 1985 Spring;9(1):113-21. doi: 10.1016/0149-7634(85)90037-5. Neurosci Biobehav Rev. 1985. PMID: 2858076 Review.
Cited by
-
Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects.Neuropsychiatr Dis Treat. 2018 May 23;14:1351-1361. doi: 10.2147/NDT.S164307. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29872302 Free PMC article. Review.
-
Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABAAR subsynaptic reorganization.Front Cell Neurosci. 2025 Jul 4;19:1624813. doi: 10.3389/fncel.2025.1624813. eCollection 2025. Front Cell Neurosci. 2025. PMID: 40686502 Free PMC article.
-
Effect of diazepam treatment and its withdrawal on pro/antioxidative processes in rat brain.Mol Cell Biochem. 2003 Mar;245(1-2):51-6. doi: 10.1023/a:1022857508987. Mol Cell Biochem. 2003. PMID: 12708744
-
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?Adv Pharmacol Sci. 2012;2012:416864. doi: 10.1155/2012/416864. Epub 2012 Mar 29. Adv Pharmacol Sci. 2012. PMID: 22536226 Free PMC article.
-
Pro and antioxidant responses to repeated administration of diazepam in rat brain.Mol Cell Biochem. 2000 Mar;206(1-2):97-103. doi: 10.1023/a:1007007630118. Mol Cell Biochem. 2000. PMID: 10839199
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources